Interest in highly potent drugs is largely driven by oncology research and more targeted therapies as they can precisely target cancer cells and reduce side effects. Given the very positive general outlook for the HPAPI market, it is integral to ensure companies have an integrated containment strategy in place – including standardized cleaning and decontamination procedures. By aligning containment strategies with risk analyses and technology transfer processes, companies can align with accelerated timelines expected for these specialty medicines.

In this short video Christian Dowdeswell explains three key trends in the Small Molecules industry today.

Content Type: Video
Watch Now
Latest content

Latest briefing from the Knowledge Center